Facilitator: Sherry Larkins, PhD, Director of International Programs and Research Sociologist, Integrated Substance Abuse Programs at the University of California, Los Angeles – Semel Institute for Neuroscience and Human Behavior

Cost: No fee

Target Audience: This activity was developed to meet the needs of physicians and all interprofessional healthcare providers.

Credit Designations Available: AMA PRA Category 1 Credit™, and Interprofessional Continuing Education (IPCE) credit.

Webinar Description: The strengths and barriers for each community and clinic vary, and there is no one-size-fits-all model for implementing medications for addiction treatment (MAT). Questions you have might have include: What models have been used to successfully scale up MAT for OUD patients? What models have specifically been used to scale up buprenorphine treatment? How do we know which model might work best in a particular setting? This session will review these questions and highlight concrete organizational and administrative steps and processes to consider when defining your own clinic’s needs in treatment delivery. We will discuss the value of developing a MAT implementation plan that includes clinical considerations, process improvement considerations, staffing, and financial considerations.

Educational Objectives:

• Review standardized substance use disorder screening tools and consider how screening can be integrated into current patient flow
• Evaluate service delivery models and identify a best fit for your site
• Develop a MAT implementation plan that includes clinical considerations, process improvement considerations, and financial considerations
• Consider clinical and organizational metrics and data that may be used for process improvement

Continuing Education Information:

In support of improving patient care, this activity has been planned and implemented by Addiction Technology Transfer Center Network and American Academy of Addiction Psychiatry. American Academy of Addiction Psychiatry is jointly accredited by the Accreditation Council for Continuing Medical Education (ACCME), the Accreditation Council for Pharmacy Education (ACPE), and the American Nurses Credentialing Center (ANCC) to provide continuing education for the healthcare team.

Interprofessional Continuing Education (IPCE) Designation Statement:

This activity was planned by and for the healthcare team, and learners will receive 1 (one) Interprofessional Continuing Education credits for learning and change.

Physician Designation Statement

American Academy of Addiction Psychiatry designates this enduring material for a maximum of 1 AMA PRA Category 1 Credits™. Physicians should claim only the credit commensurate with the extent of their participation in the activity.

Other Health Professionals

Participants will receive a Certificate of Attendance stating this program is designated for 1.0 hour AMA PRA Category 1 Credit™. This credit is accepted by the AANP and the AAPA.